Development of an antibiogram in a long-term care facility

Consultant Pharmacist

Volumn 26, Issue 11, 2011, Pages 829-836

  Phillippe, Haley M ^a   Darling, Charles H ^b   Aikens, Garrett B ^b   Wargo, Kurt A ^a  

^a AUBURN UNIVERSITY   (United States)

^b NONE

Author keywords

Antibiogram; Antimicrobial; Bacteria; Geriatric; Long term care facility; Microorganisms; Nursing facility; Resistance; Susceptibility

Indexed keywords

AMOXICILLIN; AMPICILLIN; AZTREONAM; CEFALOTIN; CEFAZOLIN; CEFEPIME; CEFTRIAXONE; CIPROFLOXACIN; CLINDAMYCIN; COLISTIMETHATE; ERTAPENEM; GENTAMICIN; LEVOFLOXACIN; LINEZOLID; NITROFURANTOIN; OXACILLIN; PIPERACILLIN PLUS TAZOBACTAM; SULFAMETHOXAZOLE; TETRACYCLINE; TOBRAMYCIN; TRIMETHOPRIM; VANCOMYCIN;

ALCALIGENES FAECALIS; ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM IDENTIFICATION; CHRONIC PATIENT; CITROBACTER FREUNDII; CITROBACTER KOSERI; ENTEROBACTER AEROGENES; ENTEROBACTER CLOACAE; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; HAEMOPHILUS INFLUENZAE; HUMAN; KLEBSIELLA PNEUMONIAE; LONG TERM CARE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORGANELLA MORGANII; PROTEUS MIRABILIS; PROTEUS VULGARIS; PROVIDENCIA STUARTII; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; SERRATIA MARCESCENS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HAEMOLYTICUS; STAPHYLOCOCCUS HOMINIS; STAPHYLOCOCCUS XYLOSUS; STENOTROPHOMONAS MALTOPHILIA; STREPTOCOCCUS PNEUMONIAE;

ALABAMA; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HEALTH FACILITIES; HUMANS; LONG-TERM CARE; MICROBIAL SENSITIVITY TESTS; RETROSPECTIVE STUDIES;

EID: 81855216227     PISSN: 08885109     EISSN: None     Source Type: Journal    
DOI: 10.4140/TCP.n.2011.829     Document Type: Article

References (20)

1. Boucher HW, Talbot GH, Bradley JS et al. Bad-bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis 2009;48:1-12.
2. Infectious Diseases Society of America. Patient Stories. http:// www.idsociety.org/badbugsnodrugspatientstories.htm. Accessed March 29, 2011.
3. Obritsch MD, Fish DN, MacLaren R et al. Nosocomial infections due to multidrug-resistant Pseudomonas aeruginosa: epidemiology and treatment options. Pharmacotherapy 2005;25:1353-64. (Pubitemid 41407633)
4. Smith P, Bennett G, Bradley S et al. SHEA/APIC Guideline: infection prevention and control in the long-term care facility. Am J Infect Control 2008;36:504-35.
5. Schwaber MJ, Navon-Venezia S, Kaye KS et al. Clinical and economic impact of bacteremia with extended-spectrum-beta-lactamase- producing Enterobacter. Antimicrob Agents Chemother 2006;50:1257-62.
6. Spellberg B, Guidos R, Gilbert D et al. The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America. Clin Infect Dis 2008;46:155-64. (Pubitemid 351269151)
7. Muder RR, Breene C, Drenning SD et al. Multiple antibiotic-resistant gram-negative bacilli in a long-term-care facility: a case control study of patient risk factors and prior antibiotic use. Infect Control Hosp Epidemiol 1997;18:809-13. (Pubitemid 127470464)
8. Weiner J, Quinn JP, Bradford PA et al. Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. JAMA 1999;281:517-23. (Pubitemid 29081304)
9. Flamm RK, Weaver MK, Thornsberry C et al. Factors associated with relative rates of antibiotic resistance in Pseudomonas aeruginosa isolates tested in clinical laboratories in the United States from 1999-2002. Antimicrob Agents Chemother 2004;48:2431-6. (Pubitemid 38823407)
10. Pop-Vicas AE, D'Agata EM. The rising influx of multi-drug-resistant gram negative bacilli into tertiary care hospital. Clin Infect Dis 2005;40:1792-8. (Pubitemid 40799949)
11. Pop-Vicas AE, Mitchell SL, Kandel R. Multidrug-resistant gram-negative bacteria in a long-term care facility: prevalence and risk factors. J Am Geriatr Soc 2008;56:1276-80.
12. O'Fallon E, Pop-Vicas A, D'Agata E. The emerging threat of multidrug-resistant gram-negative organisms in long-term care facilities. J Gerontol A Biol Sci Med Sci 2009;64A:138-41.
13. Nicolle LE, Bentley D, Garibaldi R et al. SHEA Position Paper: antimicrobial use in long-term-care facilities. Infect Control Hosp Epidemiol 1996;17:119-28. (Pubitemid 126478049)
14. Wayne SJ, Rhyne RL, Stratton M. Longitudinal prescribing patterns in a nursing home population. J Am Geriatr Soc 1992;40:53-6.
15. Mandell LA, Wunderink RG, Anzueto A et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007;44:S27-72. (Pubitemid 46290553)
16. Niederman MS, Craven DE, Bonten MJ et al. Guidelines for the management of adults with hospital-acquired, ventilatorassociated, and healthcare- associated pneumonia. Am J Respir Crit Care Med 2005;171:388-416.
17. Loeb MB, Craven S, McGeer AJ et al. Risk factors for resistance to antimicrobial agents among nursing home residents. Am J Epidemiol 2003;157:40-7. (Pubitemid 36043735)
18. CLSI. Analysis and Presentation of Cumulative Antimicrobial Susceptibility Test Data; Approved Guideline - Third Edition. CLSI document M39-A3. Wayne, PA: Clinical and Laboratory Standards Institute; 2009.
19. Lautenbach E, Marsicano R, Tolomeo P et al. Epidemiology of antimicrobial resistance among gram-negative organisms recovered from patients in a multistate network of long-term care facilities. Infect Control Hosp Epidemiol 2009;30:790-3.
20. Berard JL, Feldman SM. Identifying antimicrobial resistance patterns in long-term care: an opportunity for consultant pharmacists. Consult Pharm 1999;14:1399-403.